{
    "2019-01-16": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Adamis stock surges on release of EpiPen alternative",
                "features": {
                    "keywords": [
                        "Adamis",
                        "surges",
                        "EpiPen",
                        "alternative"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Intrexon Signs Licensing Agreement with Next Green Wave",
                "features": {
                    "keywords": [
                        "Intrexon",
                        "Licensing",
                        "Agreement",
                        "Next Green Wave"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "renewable energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-20",
                "original_text": "Tilray Teams Up With Authentic Brands, Stock Down on Sell-Off",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Authentic Brands",
                        "Stock Down",
                        "Sell-Off"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-25",
                "original_text": "6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Buy",
                        "Stock",
                        "2019"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}